TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
TRIV was delisted on the 3rd of February, 2016.
41 hedge funds and large institutions have $181M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
17% more funds holding
Funds holding: 35 → 41 (+6)
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
1% less capital invested
Capital invested by funds: $184M → $181M (-$2.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$3.06M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.55M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$1.12M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$930K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$812K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.03M |
| 2 |
Morgan Stanley
New York
|
-$422K |
| 3 |
Jane Street
New York
|
-$364K |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$289K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$267K |
TRIV Hedge Fund Activity: Q3 2014 in Review
41 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q3 2014, worth a combined $181M — down 1.4% from $184M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TRIV positions and 4 closed out — a net gain of 6 holders — while 13 added to existing stakes and 12 trimmed.
The largest buyer was Redmile Group, adding an estimated $3.06M. The largest seller was JP Morgan Chase, cutting an estimated $1.03M.
- 41 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q3 2014, up from 35 in Q2 2014.
- Funds reported $181M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q3 2014, down 1.4% quarter-over-quarter.
- 10 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q3 2014 and 4 closed out, a net change of +6 holders.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q3 2014 was Redmile Group, an estimated $3.06M added.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q3 2014 was JP Morgan Chase, an estimated $1.03M sold.
Based on aggregated 13F filings for Q3 2014.